Syntekabio Secures KRW 10B for AI Drug Development from Korea Investment Partners
Syntekabio, a leader in AI-driven drug development based in South Korea, has attracted a significant investment of KRW 10 billion from...
syntekabio
Syntekabio, a leader in AI-driven drug development based in South Korea, has attracted a significant investment of KRW 10 billion from...